Paper Details

  1. Home
  2. Paper Details

Aminosalicylates for induction of remission or response in Crohn's disease.

Author: HanauerStephen, LimWee-Chian, MacDonaldJohn K, WangYongjun

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This systematic review critically examined the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in patients with mildly to moderately active Crohn's disease. The review found that the available data on the efficacy of these medications was conflicting and required further research.
Paper Details　
Original Abstract of the Article :
Randomized trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for induc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457996/

データ提供：米国国立医学図書館（NLM）

Aminosalicylates for Crohn's Disease: Navigating a Confusing Terrain

Crohn's disease, a chronic inflammatory bowel disease, is like a treacherous desert - unpredictable and potentially debilitating. Researchers are constantly seeking new oases of treatment, and aminosalicylates have emerged as potential candidates for this challenging condition. This study delves into the complex landscape of aminosalicylates, exploring their efficacy in inducing remission or response in patients with Crohn's disease. The authors embark on a systematic review, a quest to uncover the truth amidst a landscape of conflicting research results.

A Systematic Review: Seeking Clarity in the Desert of Crohn's Disease

This systematic review navigates the complex terrain of aminosalicylates, analyzing existing research to provide a clearer picture of their effectiveness in treating Crohn's disease. The authors meticulously sift through the sands of conflicting studies, much like a skilled desert explorer searching for a reliable water source. Their findings offer valuable insights into the role of sulfasalazine and mesalamine in managing Crohn's disease, paving the way for more informed treatment decisions.

Finding a Path Through the Sandstorm: Understanding the Potential of Aminosalicylates

The results of this review emphasize the need for a more nuanced understanding of aminosalicylates in treating Crohn's disease. While their effectiveness may vary, this research provides valuable insights that can guide future treatment strategies. The authors’ findings, like a beacon in the desert, offer hope for patients seeking relief from the debilitating effects of Crohn's disease.

Dr.Camel's Conclusion

The world of Crohn's disease treatment is like a shifting desert landscape, with new discoveries constantly emerging. This systematic review sheds light on the complex role of aminosalicylates, highlighting the need for continued research and careful individualization of treatment approaches. As we continue to explore the vastness of this medical desert, understanding the nuances of each medication is crucial for providing optimal care to those seeking relief from the debilitating effects of Crohn's disease.

Date :
  1. Date Completed 2016-09-21
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

27372735

DOI: Digital Object Identifier

PMC6457996

Related Literature

Article Analysis
・Effects of olsalazine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.